Overview

A Study of SYS6010 in Combination With SYH2051 in Patients With Advanced Colorectal Cancer and Other Gastrointestinal Tumors

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2026-04-30
Target enrollment:
Participant gender:
Summary
This study is an open-label, non-randomized trial design, including a dose escalation phase and a dose expansion phase, to evaluate the safety, tolerability and preliminary anti-tumor activity of SYS6010 in combination with SYH2051 in patients with advanced gastrointestinal tumors.
Phase:
NA
Details
Lead Sponsor:
Fujian Cancer Hospital